undamentalytics Newsletter
Sign in

Genedx Holdings Corp. cash flow statement

In fiscal 2025, Genedx Holdings Corp.'s operations generated $33.3m of cash; it spent $19.0m on capital projects, leaving free cash flow of $14.3m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−19−93−190−319−180−2833−49
Depreciation and amortisation61222502081011
Stock-based pay512021942−093236
Capital spending122497551927
Free cash flow−31−117−200−326−185−3414−76
Free cash flow after stock pay−36−237−419−368−185−43−18−112
Shares issued00350198————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: PHR vs WGSHSTM vs WGSDOCS vs WGS

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Genedx Holdings Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Genedx Holdings Corp.